TB Biosciences

About:

TB Biosciences is an early-stage medical diagnostics company developing a point-of-care test for active tuberculosis.

Top Investors: NYU Innovation Venture Fund, Originate Ventures

Description:

TB Biosciences, Inc. is an early stage development medical diagnostics company founded in June 2013 to develop a rapid point-of-care tuberculosis test that meets performance standards around the world. The goal of TB Biosciences is to commercialize a simple to operate and use tuberculosis test that replaces the 125 year old sputum smear test. The Company is using an array of patented peptides developed and exclusively licensed from the NYU School of Medicine.

Total Funding Amount:

$1.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Bethlehem, Pennsylvania, United States

Founded Date:

2013-06-01

Contact Email:

info(AT)webchamp.nl

Founders:

Daniel Malamud, R. Sam Niedbala, Suman Laal, Susan Zolla, William Abrams

Number of Employees:

1-10

Last Funding Date:

2013-07-18

IPO Status:

Private

Industries: